Toshiba America Medical Systems is expanding its suite of low dose CT technologies, Target CTA and Adaptive Iterative Dose Reduction (AIDR), to reduce CT radiation dose while maintaining diagnostic confidence, for medical imaging manufacturers and healthcare facilities.
Target CTA is a cardiac protocol for the Aquilion ONE that is designed for patients including pediatrics.
Toshiba said that since the Aquilion ONE can image the entire heart in one rotation, using the Target CTA protocol allows for more accurate targeting of the heart and minimises padding of the scan range. Target CTA can be most helpful to limit radiation dose during gated cardiac studies.
Adaptive Iterative Dose Reduction (AIDR) is software that iterates noise out of the image to increase image quality and lower radiation dose. The software intuitively improves the image by removing noise until the optimal image is produced.
AIDR will come standard on the Aquilion Premium edition and Aquilion ONE.
Toshiba CT Business Unit director Joseph Cooper said that Target CTA and AIDR represent Toshiba’s continued commitment to providing patients with safer CT exams without sacrificing the diagnostic confidence physicians require.
"These technologies expand the full suite of dose reduction technologies as Toshiba continues to innovate new ways to provide safer CT exams to patients," Cooper said.
Target CTA and AIDR join a full lineup of Toshiba dose reduction technologies, including SUREExposure, SUREExposure Pediatric, QDS and Boost3D.